menu
    • menu
    [{"orgOrder":0,"company":"THINQ Pharma-CRO PVT Ltd","sponsor":"Unique Pharmaceuticals Ltd, India | THINQ Pharma-CRO PVT Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Clotrimazole","moa":"Cytochrome P450 51","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"THINQ Pharma-CRO PVT Ltd","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"THINQ Pharma-CRO PVT Ltd \/ Unique Pharmaceuticals Ltd, India | THINQ Pharma-CRO PVT Ltd","highestDevelopmentStatusID":"10","companyTruncated":"THINQ Pharma-CRO PVT Ltd \/ Unique Pharmaceuticals Ltd, India | THINQ Pharma-CRO PVT Ltd"}]

    Find Clinical Drug Pipeline Developments & Deals by THINQ Pharma-CRO PVT Ltd

    Menu

    THINQ Pharma-CRO PVT Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            THINQ Pharma-CRO PVT Ltd

                            India arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            THINQ Pharma-CRO PVT Ltd

                            India arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Clotrimazole

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Unique Pharmaceuticals Ltd, India | THINQ Pharma-CRO PVT Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges U...

                            Details : Clotrimazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Candidiasis, Oral.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 18, 2015

                            Lead Product(s) : Clotrimazole

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Unique Pharmaceuticals Ltd, India | THINQ Pharma-CRO PVT Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth